Fermented Moringa oleifera Decreases Hepatic Adiposity and Ameliorates Glucose Intolerance in High-Fat Diet-Induced Obese Mice

다국어 초록 (Multilingual Abstract)

Metabolic diseases, such as glucose intolerance and nonalcoholic fatty-liver disease (NAFLD), are primary risk factors for life-threatening conditions such as diabetes, heart attack, stroke, and hepatic cancer. Extracts from the tropical tree Moringa oleifera show antidiabetic, antioxidant, anti-inflammatory, and anticancer effects. Fermentation can further improve the safety and nutritional value of certain foods. We investigated the efficacy of fermented M. oleifera extract (FM) against high-fat diet (HFD)-induced glucose intolerance and hepatic lipid accumulation and investigated the underlying mechanisms by analyzing expression of proteins and genes involved in glucose and lipid regulation. C57BL/6 mice were fed with normal chow diet (ND) or HFD supplemented with distilled water (DW, control), nonfermented M. oleifera extract (NFM), or FM for 10 weeks. Although body weights were similar among HFD-fed treatment groups, liver weight was decreased, and glucose tolerance test (GTT) results improved in the FM group compared with DW and NFM groups. Hepatic lipid accumulation was also lower in the FM group, and expressions of genes involved in liver lipid metabolism were upregulated. In addition, HFD-induced endoplasmic reticulum (ER) stress, oxidative stress, and lipotoxicity in quadriceps muscles were decreased by FM. Finally, proinflammatory cytokine mRNA expression was decreased by FM in the liver, epididymal adipose tissue, and quadriceps of HFD-fed mice. FMs may decrease glucose intolerance and NAFLD under HFDinduced obesity by decreasing ER stress, oxidative stress, and inflammation.

참고문헌 (Reference)

1 Fu S, "The role of endoplasmic reticulum in hepatic lipid homeostasis and stress signaling" 15 : 624-634, 2012

2 Schrauwen P, "The effect of weight reduction on skeletal muscle UCP2 and UCP3 mRNA expression and UCP3 protein content in Type II diabetic subjects" 43 : 1408-1416, 2000

3 Al-Malki AL, "The antidiabetic effect of low doses of Moringa oleifera Lam. Seeds on streptozotocin induced diabetes and diabetic nephrophthy in male rats" 2015 : 381040-, 2015

4 Salvado´ L, "Targeting endoplasmic reticulum stress in insulin resistance" 26 : 438-448, 2015

5 Waterman C, "Stable, water extractable isothiocyanates from Moringa oleifera leaves attenuate inflammation in vitro" 103 : 114-122, 2014

6 Jung IL, "Soluble extract from Moringa oleifera leaves with a new anticancer activity" 9 : e95492-, 2014

7 Stohs SJ, "Review of the safety and efficacy of Moringa oleifera" 29 : 796-804, 2015

8 Bosma M, "Reevaluating lipotoxic triggers in skeletal muscle : Relating intramyocellular lipid metabolism to insulin sensitivity" 51 : 36-49, 2012

9 Rieusset J, "Reduction of endoplasmic reticulum stress using chemical chaperones or Grp78overexpression does not protect muscle cells from palmitateinduced insulin resistance" 417 : 439-445, 2012

10 Ji C, "Postnatal overfeeding promotes early onset and exaggeration of high-fat diet-induced nonalcoholic fatty liver disease through disordered hepatic lipid metabolism in rats" 25 : 1109-1116, 2014

11 Rains JL, "Oxidative stress, insulin signaling, and diabetes" 50 : 567-575, 2011

12 Henriksen EJ, "Oxidative stress and the etiology of insulin resistance and type 2 diabetes" 51 : 993-999, 2011

13 Rinella ME, "Nonalcoholic fatty liver disease : A systemic review" 313 : 2263-2273, 2015

14 Gaggini M, "Non-alcoholic fatty liver disease(NAFLD)and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease" 5 : 1544-1560, 2013

15 Flamment M, "New insights into ER stress-induced insulin resistance" 23 : 381-390, 2012

16 Byrne CD, "NAFLD: A multisystem disease" 68 : S47-S64, 2015

17 Olayaki LA, "Methanolic extract of Moringa oleifera leaves improves glucose tolerance, glycogen synthesis and lipid metabolism in alloxan-induced diabetic rats" 26 : 585-593, 2015

18 Ford RJ, "Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity" 468 : 125-132, 2015

19 Højlund K, "Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance" 61 : B4890-, 2014

20 Mead JR, "Lipoprotein lipase : Structure, function, regulation, and role in disease" 80 : 753-769, 2002

21 Waterman C, "Isothiocyanaterich Moringa oleifera extract reduces weight gain, insulin resistance, and hepatic gluconeogenesis in mice" 59 : 1013-1024, 2015

22 Wilson CG, "Hepatocyte-specific disruption of CD 36 attenuates fatty liver and improves insulin sensitivity in HFD-fed mice" 157 : 570-585, 2016

23 Alberdi G, "Hepatic lipid metabolic pathways modified by resveratrol in rats fed an obesogenic diet" 29 : 562-567, 2013

24 Strable MS, "Genetic control of de novo lipogenesis : Role in diet-induced obesity" 45 : 199-214, 2010

25 Bergman RN, "Free fatty acids and pathogenesis of type 2 diabetes mellitus" 11 : 351-356, 2000

26 Bourdichon F, "Food fermentations : Microorganisms with technological beneficial use" 154 : 87-97, 2012

27 Dai F, "Fenofibrate improves high-fat diet-induced and palmitateinduced endoplasmic reticulum stress and inflammation in skeletal muscle" 157 : 158-167, 2016

28 Zechner R, "FAT SIGNALS-lipases and lipolysis in lipid metabolism and signaling" 15 : 279-291, 2012

29 Di Cagno R, "Exploitation of vegetables and fruits through lactic acid fermentation" 33 : 1-10, 2013

30 Tumer TB, "Direct and indirect antioxidant activity of polyphenol-and isothiocyanate-enriched fractions from Moringa oleifera" 63 : 1505-1513, 2015

31 Castro G, "Diet-induced obesity induces endoplasmic reticulum stress and insulin resistance in the amygdala of rats" 3 : 443-449, 2013

32 Leone A, "Cultivation, genetic, ethnopharmacology, phytochemistry and pharmacology of Moringa oleifera leaves : An overview" 16 : 12791-12835, 2015

33 Bennett WL, "Comparative effectiveness and safety of medications for type 2 diabetes : An update including new drugs and 2-drug combinations" 154 : 602-613, 2011

34 Wu Y, "Chronic inflammation exacerbates glucose metabolism disorders in C57BL/6J mice fed with highfat diet" 219 : 195-204, 2013

35 Madiraju AK, "Argininosuccinate synthetase regulates hepatic AMPK linking protein catabolism and ureagenesis to hepatic lipid metabolism" 113 : E3423-E3430, 2016

36 Gautam J, "An isoflavone cladrin prevents high-fat diet-induced bone loss and inhibits the expression of adipogenic gene regulators in 3T3-L1 adipocyte" 68 : 1051-1063, 2016

37 Gautam S, "Aegeline from Aegle marmelos stimulates glucose transport via Akt and Rac1 signaling, and contributes to a cytoskeletal rearrangement through PI3K/Rac1" 762 : 419-429, 2015

38 Ouwehand AC, "Advances in Fermented Foods and Beverages" Elsevier 3-22, 2016

39 Zhang BB, "AMPK : An emerging drug target for diabetes and the metabolic syndrome" 9 : 407-416, 2009

40 van Dijk SJ, "A saturated fatty acidrich diet induces an obesity-linked proinflammatory gene expression profile in adipose tissue of subjects at risk of metabolic syndrome" 90 : 1656-1664, 2009

41 Liu Q, "1-Deoxynojirimycin alleviates insulin resistance via activation of insulin signaling PI3K/AKT pathway in skeletal muscle of db/db mice" 20 : 21700-21714, 2015